Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 219

1.

Liquid Biopsy in Thyroid Cancer: New Insight.

Khatami F, Tavangar SM.

Int J Hematol Oncol Stem Cell Res. 2018 Jul 1;12(3):235-248. Review.

2.

Concise Review on Clinical Applications of Conditioned Medium Derived from Human Umbilical Cord-Mesenchymal Stem Cells (UC-MSCs).

Sriramulu S, Banerjee A, Di Liddo R, Jothimani G, Gopinath M, Murugesan R, Marotta F, Pathak S.

Int J Hematol Oncol Stem Cell Res. 2018 Jul 1;12(3):230-234. Review.

3.

Differentiation of Wharton's Jelly Derived Mesenchymal Stem Cells into Insulin Producing Cells.

Ranjbaran H, Abediankenari S, Khalilian A, Rahmani Z, Momeninezhad Amiri M, Hosseini Khah Z.

Int J Hematol Oncol Stem Cell Res. 2018 Jul 1;12(3):220-229.

4.

Challenges of Establishing a National Rare Donor Program in Iran.

Ghezelbash B, Moghaddam M, Aghazadeh S.

Int J Hematol Oncol Stem Cell Res. 2018 Jul 1;12(3):213-219.

5.

Cytotoxic and Apoptogenic Activity of Bryonia aspera Extract on Pre-B Acute Lymphoblastic Leukemia Cell Lines.

Yazdanpanah S, Esmaeili S, Bashash D, Dehghan Nayeri N, Esfini Farahani M, Gharehbaghian A.

Int J Hematol Oncol Stem Cell Res. 2018 Jul 1;12(3):204-212.

6.

Experience of Sorafenib as First-Line Treatment in Metastatic Renal Cell Carcinoma in a Tertiary Care Centre.

Saxena M, Madabhavi I, Patel A, Panchal H, Anand A.

Int J Hematol Oncol Stem Cell Res. 2018 Jul 1;12(3):197-203.

7.

Successful Outcome of Autologous Stem Cell Transplantation for Relapsed or Refractory Germ Cell Tumors.

Mousavi SA, Abedinzadeh N, Taj L, Kasaeian A, Alimoghaddam K, Vaezi M, Zokaasadi M, Kamranzadeh Fumani H, Ghavamzadeh A.

Int J Hematol Oncol Stem Cell Res. 2018 Jul 1;12(3):192-196.

8.

The Role of Donor Leukocyte Infusions in the Treatment of Relapsed Acute Leukemia after Allogeneic Stem Cell Transplantation: A Retrospective Analysis.

Vaezi M, Zokaasadi M, Shahsavari Pour S, Kasaeian A, Nikbakht M, Kamranzadeh Fumani H, Alimoghaddam K, Ghavamzadeh A.

Int J Hematol Oncol Stem Cell Res. 2018 Jul 1;12(3):185-191.

9.

First Report of Known Rare Rhnull Phenotype Individuals in Iran.

Shahverdi E, Moghaddam M, Abolghasemi H.

Int J Hematol Oncol Stem Cell Res. 2018 Jul 1;12(3):181-184.

10.

The Relationship between Primary Hyperparathyroidism and Thrombotic Events: Report of Three Cases and a Review of Potential Mechanisms.

Koufakis T, Antonopoulou V, Grammatiki M, Karras SN, Ajjan R, Zebekakis P, Kotsa K.

Int J Hematol Oncol Stem Cell Res. 2018 Jul 1;12(3):175-180.

11.

Cultured Cells Isolated from CNS Indolent B-Cell Lymphoma Have Characteristics of Mesenchymal Stem Cells: A Clinical Case and Scientific Research.

Tumagelova-Yuzeir K, Ivanova-Todorova E, Naydenov E, Velikova T, Krasimirova E, Belemezova K, Dikov T, Penkov M, Nachev S, Genova M, Kyurkchiev D.

Int J Hematol Oncol Stem Cell Res. 2018 Jul 1;12(3):169-174.

12.

Primary Vaginal Chloroma: A Rare Case Report.

Madabhavi I, Patel A, Modi M, Revannasiddaiah S, Chavan C.

Int J Hematol Oncol Stem Cell Res. 2018 Jul 1;12(3):166-168.

13.

Role of Hippo Pathway Effector Tafazzin Protein in Maintaining Stemness of Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSC).

Gopinath M, Di Liddo R, Marotta F, Murugesan R, Banerjee A, Sriramulu S, Jothimani G, Subramaniam VD, Narasimhan S, Priya K S, Sun XF, Pathak S.

Int J Hematol Oncol Stem Cell Res. 2018 Apr 1;12(2):153-165.

14.

Factors Affecting the Incidence and Severity of Oral Mucositis Following Hematopoietic Stem Cell Transplantation.

Valeh M, Kargar M, Mansouri A, Kamranzadeh H, Gholami K, Heidari K, Hajibabaei M.

Int J Hematol Oncol Stem Cell Res. 2018 Apr 1;12(2):142-152.

15.

Bevacizumab Inhibits Angiogenic Cytokines in Head and Neck Squamous Cell Carcinoma: From Gene to the Protein.

Heydar H, Mansouri K, Norooznezhad M, Norooznezhad F, Mohamadnia A, Bahrami N.

Int J Hematol Oncol Stem Cell Res. 2018 Apr 1;12(2):136-141.

16.

T-Cell Prolymphocytic Leukemia: An Experience from a Tertiary Cancer Centre in South India.

Babu Mc S, Anand A, Lakshmaiah KC, Babu K G, Lokanatha D, Jacob LA, Madhumathi DS, Lokesh KN, Rudresha AH, Rajeev LK, Patidar R.

Int J Hematol Oncol Stem Cell Res. 2018 Apr 1;12(2):132-135.

17.

The Confirmation of Safety for the Intensified Conditioning Regimens: A Retrospective Study of Allogeneic Hematopoietic Stem Cell Transplantation for Non-Remission Hematological Malignant Diseases.

Yoshida S, Henzan H, Ueno T, Shimakawa T, Matsuo Y, Kuriyama T, Saito N, Kawano I, Numata A, Takase K, Iino T, Eto T.

Int J Hematol Oncol Stem Cell Res. 2018 Apr 1;12(2):123-131.

18.

Cholelithiasis in Thalassemia Major Patients: A Report from the South-East of Iran.

Shahramian I, Behzadmehr R, Afshari M, Allahdadi A, Delaramnasab M, Bazi A.

Int J Hematol Oncol Stem Cell Res. 2018 Apr 1;12(2):117-122.

19.

A Review of Allogeneic Hematopoietic Stem Cell Transplantation in Metastatic Breast Cancer.

Karadurmus N, Sahin U, Bahadir Basgoz B, Arpaci F, Demirer T.

Int J Hematol Oncol Stem Cell Res. 2018 Apr 1;12(2):111-116. Review.

20.

Investigation of CCR7 Marker Expression Using Immunohistochemical Method and Its Association with Clinicopathologic Properties in Patients with Breast Cancer.

Vahedi L, Ghasemi M, Yazdani J, Ranjbar S, Nouri B, Alizadeh A, Afshar P.

Int J Hematol Oncol Stem Cell Res. 2018 Apr 1;12(2):103-110.

Supplemental Content

Loading ...
Support Center